The Pharmagellan Guide to Biotech Forecasting and Valuation
Frank S. David, Seth Robey, Andrew Matthews
评分 暂无
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser—or aspire to be one—then you need to build and analyze forecasts and valuations of R&D-stage drugs. This book is for you.
